Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001842952-22-000052
Filing Date
2022-06-03
Accepted
2022-06-03 16:04:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 prosuppfor8-kjune32022a.htm 424B3 29700
2 image_0.jpg GRAPHIC 47702
  Complete submission text file 0001842952-22-000052.txt   92344
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261599 | Film No.: 22994293
SIC: 2834 Pharmaceutical Preparations